US2013137651A1PendingUtilityA1
Gel useful for the delivery of ophthalmic drugs
Assignee: IND FARMACEUTICHE RIUNITE S P A SIGMA TAUPriority: Dec 22, 2006Filed: Jan 25, 2013Published: May 30, 2013
Est. expiryDec 22, 2026(~0.4 yrs left)· nominal 20-yr term from priority
A61K 9/0048A61K 47/12A61K 47/32A61K 31/205A61K 45/06A61P 27/02A61K 9/06A61K 9/19A61K 47/26A61K 31/7036A61K 9/14
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a solid powder composed of a mixture of a natural or a synthetic polymer which forms a gel, a buffer, such as an hydroxyacid or a dicarboxyacid, a saccharide, one or more drugs useful for the treatment of diseases of the eyes and optionally one or more excipients and/or regulators of the osmotic pressure ophthalmologically acceptable.
Claims
exact text as granted — not AI-modified1 . A solid powder comprising:
a carboxy vinyl polymer; a buffer; a saccharide; and L-carnitine and/or one or more alkanoyl L-carnitine, said solid powder providing a gel suitable for ophthalmic use when reconstituted in water.
2 . The solid powder of claim 1 , wherein the carboxy vinyl polymer is carbopol.
3 . The solid powder of claim 1 , wherein the buffer is a hydroxyacid or a dicarboxylic acid selected from the group consisting of phosphate, boric acetate, citrate, lactate, tartrate, maleate, succinate and fumarate buffer.
4 . The solid powder of claim 1 , wherein the saccharide is selected from the group consisting of glucose, fructose, mannitol, sorbitol, lactose, trehalose and maltose.
5 . The solid powder of claim 1 , further comprising an excipient, a diluent or a regulator of the osmotic pressure ophthalmologically acceptable.
6 . Physiological supplement comprising the solid powder of claim 1 and further comprising:
L-carnitine
1%;
taurine
0.5%;
sodium hyaluronate
0.2%;
vitamin E
0.2%;
manganese
0.051%;
zinc
1.02%;
sodium
30 mg/L;
potassium
9 mg/L.
7 . Physiological supplement comprising the solid powder of claim 1 and further comprising:
L-carnitine
10%;
taurine
2%;
sodium hyaluronate
0.2%;
vitamin E
0.2%;
zinc
1.02 mg/L;
manganese
0.051 mg/L;
sodium
30 mg/L;
potassium
9 mg/L.
8 . Physiological supplement comprising the solid powder of claim 1 and further comprising:
L-carnitine
5%;
3-Hydroxykynurenine O-P-DL-glucoside
0.1 mg/mL;
taurine
2%;
resveratrol
0.3 mg/mL;
sodium jaluronate
0.2%;
vitamin E
0.2%;
zinc
1.02 mg/L;
manganese
0.051 mg/L;
sodium
30 mg/L;
potassium
9 mg/L.
9 . Physiological supplement comprising the solid powder of claim 1 and further comprising:
acetyl L-carnitine
20%;
3-Hydroxykynurenine O-β-DL-glucoside
0.1 mg/mL;
vitamin E
1%;
vitamin A
25000 UI.
10 . Kit comprising the solid powder of claim 1 and water or a liquid solution.
11 . Kit of claim 10 , in which each component is packaged in the same vial or in two different vials.
12 . Kit comprising:
a) the powder of claim 1 , without L-carnitine and/or one or more alkanoyl L-carnitine; b) L-carnitine and/or one or more alkanoyl L-carnitine in the form of liquid, solid, cream, gel or powder; and c) water or a liquid solution.
13 . Kit of claim 12 , wherein each component is packaged in a separate form in the same vial or in different vials.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.